Clinical Trial Update: Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating paclitaxel and carboplatin with or without metformin in advanced or recurrent endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Adenocarcinoma
• Endometrial Clear Cell Adenocarcinoma
• Endometrial Serous Adenocarcinoma
• Endometrial Undifferentiated Carcinoma
• Uterine Corpus Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)
• PACLITAXEL (PACLITAXEL)
• Paclitaxel and Carboplatin with or without Metformin

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma | Phase 2, Phase 3 | Status: UNKNOWN | Results posted: 2021-01-12